Congratulations to Congruence Therapeutics
Congratulations to Congruence Therapeutics on the appointment of Frank Taffy, JD as Chief Business Officer! Clarissa Desjardins, CEO, is a proven innovator, entrepreneur, and company builder who has assembled a world class team to at Congruence to advance the field of AI/ML enabled computational drug discovery. GSS is privileged to have supported Congruence Therapeutics in their mission to advance their proprietary scalable platform and develop a pipeline of small molecule correctors to address a wide range of diseases and indications that present high unmet need. The future is bright for Congruence and we look forward to witnessing their continued growth and success.